Microbial platform technology for recombinant antibody fragment production: a review
SK Gupta, P Shukla - Critical reviews in microbiology, 2017 - Taylor & Francis
Recombinant antibody fragments are being used for the last few years as an important
therapeutic protein to cure various critical and life threatening human diseases. Several …
therapeutic protein to cure various critical and life threatening human diseases. Several …
Bioengineering of antibody fragments: challenges and opportunities
S Pirkalkhoran, WR Grabowska, HH Kashkoli… - Bioengineering, 2023 - mdpi.com
Antibody fragments are used in the clinic as important therapeutic proteins for treatment of
indications where better tissue penetration and less immunogenic molecules are needed …
indications where better tissue penetration and less immunogenic molecules are needed …
Evolution of Escherichia coli Expression System in Producing Antibody Recombinant Fragments
A Sandomenico, JP Sivaccumar, M Ruvo - International Journal of …, 2020 - mdpi.com
Antibodies and antibody-derived molecules are continuously developed as both therapeutic
agents and key reagents for advanced diagnostic investigations. Their application in these …
agents and key reagents for advanced diagnostic investigations. Their application in these …
Cell-free synthesis meets antibody production: a review
M Stech, S Kubick - Antibodies, 2015 - mdpi.com
Engineered antibodies are key players in therapy, diagnostics and research. In addition to
full size immunoglobulin gamma (IgG) molecules, smaller formats of recombinant …
full size immunoglobulin gamma (IgG) molecules, smaller formats of recombinant …
Recombinant antibody production evolves into multiple options aimed at yielding reagents suitable for application-specific needs
A De Marco - Microbial cell factories, 2015 - Springer
Background Antibodies have been a pillar of basic research, while their relevance in clinical
diagnostics and therapy is constantly growing. Consequently, the production of both …
diagnostics and therapy is constantly growing. Consequently, the production of both …
Production of recombinant antibody fragments in Bacillus megaterium
E Jordan, M Hust, A Roth, R Biedendieck… - Microbial cell …, 2007 - Springer
Background Recombinant antibodies are essential reagents for research, diagnostics and
therapy. The well established production host Escherichia coli relies on the secretion into …
therapy. The well established production host Escherichia coli relies on the secretion into …
Making antibodies in bacteria
FA Fellouse, SS Sidhu - Making and using antibodies, 2006 - taylorfrancis.com
Phage-Displayed Library.................................................. 169 8.3. 2.4 Preparation of
Electrocompetent E. coli SS320.............. 170 8.3. 2.5 E. coli Electroporation and Phage …
Electrocompetent E. coli SS320.............. 170 8.3. 2.5 E. coli Electroporation and Phage …
Single-chain antibody fragments: Purification methodologies
LP Malpiedi, CA Diaz, BB Nerli, A Pessoa Jr - Process Biochemistry, 2013 - Elsevier
At present, single-chain variable fragments (scFv) of antibodies are considered one of the
most important tools in human therapies. Wide applications of antibodies are being …
most important tools in human therapies. Wide applications of antibodies are being …
Microbials for the production of monoclonal antibodies and antibody fragments
O Spadiut, S Capone, F Krainer, A Glieder… - Trends in …, 2014 - cell.com
Monoclonal antibodies (mAbs) and antibody fragments represent the most important
biopharmaceutical products today. Because full length antibodies are glycosylated …
biopharmaceutical products today. Because full length antibodies are glycosylated …
Evaluation of scFv protein recovery from E. coli by in vitro refolding and mild solubilization process
Background The production of therapeutically active single chain variable fragment (scFv)
antibody is still challenging in E. coli due to the aggregation propensity of recombinant …
antibody is still challenging in E. coli due to the aggregation propensity of recombinant …